This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Corvol, P. Articles by Jeunemaitre, X. Search for Related Content PubMed PubMed Citation Articles by Corvol, P. Articles by Jeunemaitre, X.

Molecular Genetics of Human Hypertension: Role of Angiotensinogen¹

INSERM U36, Collège de France, 75005 Paris, France

I. Introduction

II. Structure of the AGT Gene

III. Characteristics of AGT

A. AGT as the substrate for renin

B. AGT as a member of the serpin superfamily: other roles for AGT?

IV. Tissue and Cellular Distribution

V. Regulation

A. Hormonal regulation of AGT

B. Regulation of AGT in disease

C. Regulation of AGT gene transcription

VI. Molecular Genetics of AGT in Human Essential Hypertension

A. Strategies

B. Linkage studies

C. Association studies of AGT polymorphism and high blood pressure

D. Pregnancy-induced hypertension

E. M235T variants, plasma AGT concentration, and blood pressure

F. Association of AGT variants with the renal blood flow response to Ang II infusion

VII. Molecular Genetics of AGT and Other Diseases

A. AGT variants and coronary heart disease

B. AGT variants and complications of diabetes

C. AGT, obesity, and blood pressure

VIII. Effects of AGT Gene Variants and Gene Targeting on Ang I Production and Blood Pressure

A. Human studies

B. Genetic studies in rats and mice

C. Genetic hypertension in rats

D. Antisense AGT oligodeoxynucleotides

E. Transgenic animals

F. AGT gene duplication

IX. Conclusions and Perspectives

This article has been cited by other articles:

				F. Vincent, P. Bonnin, M. Clemessy, J.-O. Contreres, N. Lamande, J.-M. Gasc, J. Vilar, P. Hainaud, G. Tobelem, P. Corvol, et al. Angiotensinogen Delays Angiogenesis and Tumor Growth of Hepatocarcinoma in Transgenic Mice Cancer Res., April 1, 2009; 69(7): 2853 - 2860. [Abstract] [Full Text] [PDF]

				S. Sriramula, M. Haque, D. S.A. Majid, and J. Francis Involvement of Tumor Necrosis Factor-{alpha} in Angiotensin II-Mediated Effects on Salt Appetite, Hypertension, and Cardiac Hypertrophy Hypertension, May 1, 2008; 51(5): 1345 - 1351. [Abstract] [Full Text] [PDF]

				T. V. Pereira, A. C.F. Nunes, M. Rudnicki, Y. Yamada, A. C. Pereira, and J. E. Krieger Meta-Analysis of the Association of 4 Angiotensinogen Polymorphisms With Essential Hypertension: A Role Beyond M235T? Hypertension, March 1, 2008; 51(3): 778 - 783. [Abstract] [Full Text] [PDF]

				S. Jain, Y. Li, S. Patil, and A. Kumar HNF-1{alpha} plays an important role in IL-6-induced expression of the human angiotensinogen gene Am J Physiol Cell Physiol, July 1, 2007; 293(1): C401 - C410. [Abstract] [Full Text] [PDF]

				H. Schmidt, Y. S. Aulchenko, N. Schweighofer, R. Schmidt, S. Frank, G. M. Kostner, E. Ott, and C. van Duijn Angiotensinogen Promoter B-Haplotype Associated With Cerebral Small Vessel Disease Enhances Basal Transcriptional Activity Stroke, November 1, 2004; 35(11): 2592 - 2597. [Abstract] [Full Text] [PDF]

				T. A. Manolio, E. Boerwinkle, C. J. O'Donnell, and A. F. Wilson Genetics of Ultrasonographic Carotid Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1567 - 1577. [Abstract] [Full Text] [PDF]

				Y. Guo, E. Mascareno, and M. A. Q. Siddiqui Distinct Components of Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway Mediate the Regulation of Systemic and Tissue Localized Renin-Angiotensin System Mol. Endocrinol., April 1, 2004; 18(4): 1033 - 1041. [Abstract] [Full Text] [PDF]

				Y. Shimamoto, J. Ishida, K. Yamagata, T. Saito, H. Kato, T. Matsuoka, K. Hirota, H. Daitoku, M. Nangaku, K. Yamagata, et al. Inhibitory Effect of the Small Heterodimer Partner on Hepatocyte Nuclear Factor-4 Mediates Bile Acid-induced Repression of the Human Angiotensinogen Gene J. Biol. Chem., February 27, 2004; 279(9): 7770 - 7776. [Abstract] [Full Text] [PDF]

				S. Jain, X. Tang, C. S. Narayanan, Y. Agarwal, S. M. Peterson, C. D. Brown, J. Ott, and A. Kumar Angiotensinogen Gene Polymorphism at -217 Affects Basal Promoter Activity and Is Associated with Hypertension in African-Americans J. Biol. Chem., September 20, 2002; 277(39): 36889 - 36896. [Abstract] [Full Text] [PDF]

				A. R. Brasier, A. Recinos III, and M. S. Eledrisi Vascular Inflammation and the Renin-Angiotensin System Arterioscler. Thromb. Vasc. Biol., August 1, 2002; 22(8): 1257 - 1266. [Abstract] [Full Text] [PDF]

				J. Celerier, A. Cruz, N. Lamande, J.-M. Gasc, and P. Corvol Angiotensinogen and Its Cleaved Derivatives Inhibit Angiogenesis Hypertension, February 1, 2002; 39(2): 224 - 228. [Abstract] [Full Text] [PDF]

				R. S. Danziger Hypertension in an Anthropological and Evolutionary Paradigm Hypertension, July 1, 2001; 38(1): 19 - 22. [Full Text] [PDF]

				C. T. Sherman and A. R. Brasier Role of Signal Transducers and Activators of Transcription 1 and -3 in Inducible Regulation of the Human Angiotensinogen Gene by Interleukin-6 Mol. Endocrinol., March 1, 2001; 15(3): 441 - 457. [Abstract] [Full Text]

				M. Azizi, M.-C. Hallouin, X. Jeunemaitre, T. T. Guyene, and J. Ménard Influence of the M235T Polymorphism of Human Angiotensinogen (AGT) on Plasma AGT and Renin Concentrations after Ethinylestradiol Administration J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4331 - 4337. [Abstract] [Full Text]

				S. B. Harrap, A. D. Cumming, D. L. Davies, C. J. W. Foy, R. Fraser, A. Kamitani, J. M. Connor, A. F. Lever, and G. C. M. Watt Glomerular Hyperfiltration, High Renin, and Low- Extracellular Volume in High Blood Pressure Hypertension, April 1, 2000; 35(4): 952 - 957. [Abstract] [Full Text] [PDF]

				J. Celerier, G. Schmid, J.-P. Le Caer, A.-P. Gimenez-Roqueplo, D. Bur, A. Friedlein, H. Langen, P. Corvol, and X. Jeunemaitre Characterization of a Human Angiotensinogen Cleaved in Its Reactive Center Loop by a Proteolytic Activity from Chinese Hamster Ovary Cells J. Biol. Chem., March 31, 2000; 275(14): 10648 - 10654. [Abstract] [Full Text] [PDF]

				J. Bohlender, J. Menard, D. Ganten, and F. C. Luft Angiotensinogen Concentrations and Renin Clearance : Implications for Blood Pressure Regulation Hypertension, March 1, 2000; 35(3): 780 - 786. [Abstract] [Full Text] [PDF]

				O. A. Carretero and S. Oparil Essential Hypertension : Part I: Definition and Etiology Circulation, January 25, 2000; 101(3): 329 - 335. [Full Text] [PDF]

				C. Fardella, P. Zamorano, L. Mosso, L. Gomez, M. Pinto, J. Soto, E. Oestreicher, P. Cortes, X. Claverie, and J. Montero A-6G Variant of Angiotensinogen Gene and Aldosterone Levels in Hypertensives Hypertension, October 1, 1999; 34(4): 779 - 781. [Abstract] [Full Text] [PDF]

				J. Karjalainen, U. M. Kujala, A. Stolt, M. Mantysaari, M. Viitasalo, K. Kainulainen, and K. Kontula Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes J. Am. Coll. Cardiol., August 1, 1999; 34(2): 494 - 499. [Abstract] [Full Text] [PDF]

				J. Baima, M. Nicolaou, F. Schwartz, A. L. DeStefano, A. Manolis, I. Gavras, C. Laffer, F. Elijovich, L. Farrer, C. T. Baldwin, et al. Evidence for Linkage Between Essential Hypertension and a Putative Locus on Human Chromosome 17 Hypertension, July 1, 1999; 34(1): 4 - 7. [Abstract] [Full Text] [PDF]

				P. Corvol, A. Persu, A.-P. Gimenez-Roqueplo, and X. Jeunemaitre Seven Lessons From Two Candidate Genes in Human Essential Hypertension : Angiotensinogen and Epithelial Sodium Channel Hypertension, June 1, 1999; 33(6): 1324 - 1331. [Abstract] [Full Text] [PDF]

				H. M. Siragy, T. Inagami, T. Ichiki, and R. M. Carey Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor PNAS, May 25, 1999; 96(11): 6506 - 6510. [Abstract] [Full Text] [PDF]

				A.-P. Gimenez-Roqueplo, J. Celerier, G. Schmid, P. Corvol, and X. Jeunemaitre Role of Cysteine Residues in Human Angiotensinogen. CYS232 IS REQUIRED FOR ANGIOTENSINOGEN-PRO MAJOR BASIC PROTEIN COMPLEX FORMATION J. Biol. Chem., December 18, 1998; 273(51): 34480 - 34487. [Abstract] [Full Text] [PDF]

				A.-P. Gimenez-Roqueplo, J. Celerier, G. Lucarelli, P. Corvol, and X. Jeunemaitre Role of N-Glycosylation in Human Angiotensinogen J. Biol. Chem., August 14, 1998; 273(33): 21232 - 21238. [Abstract] [Full Text] [PDF]